Evaluation of the Diagnostic Value of the Cluster of Differentiation 10 in the Diagnosis of Follicular Thyroid Carcinoma

Seyed Ziaeddin Rasihashemi; Monireh Halimi; Nikzad Shahidi; Somayyeh Moein

E-ISSN : 2148-9696

Crescent Journal of
Medical and Biological Sciences

Main Page Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Oct 2021, Vol 8, Issue 4

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
Evaluation of the Diagnostic Value of the Cluster of Differentiation 10 in the Diagnosis of Follicular Thyroid Carcinoma
Seyed Ziaeddin Rasihashemi¹, Monireh Halimi², Nikzad Shahidi³, Somayyeh Moein³
¹Department of Cardiothoracic Surgery, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran ²Department of Pathology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran ³Department of Otorhinolaryngology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
CJMB 2021; 8: 264-268 Viewed : 2010 times Downloaded : 1555 times. Keywords : Follicular Adenocarcinoma, Papillary Carcinoma, CD10
Full Text(PDF) \| Related Articles
Abstract

Objectives: Few studies have so far focused on the role of the cluster of differentiation 10 (CD10) in the prognosis of papillary thyroid carcinoma in Iran. Accordingly, this study aimed at evaluating the diagnostic value of CD10 in follicular thyroid carcinoma. Materials and Methods: This cross-sectional study was performed on 89 patients with thyroid carcinoma at Imam Reza Hospital (Tabriz Medical Sciences) during 2016-2017. The diagnostic value of the CD10 test was evaluated for the accurate diagnosis of papillary thyroid carcinoma. Finally, data were analyzed using Mann-Whitney, chi-square, and Pearson correlation tests. Results: Among the studied samples by the CD10 method, it was found that 41 (46.06%) and 48 (53.94%) were positive and negative, respectively. There was a significant correlation between CD10 expression and tumor size (P = 0.0001), as well as lymph node involvement (P = 0.031) and capsular invasion (P = 0.008). Conclusions: In general, the CD10 biomarker could be an accessory diagnostic tool in addition to basic methods in the diagnosis of the follicular variant of papillary carcinoma although its diagnostic value in follicular carcinoma is not sufficiently high.